Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC
LSLNB
Value of Sentinel Lymph Node Biopsy to Lateral Neck Lymph Node in Thyroid Carcinoma: Prospective Study
1 other identifier
interventional
278
1 country
1
Brief Summary
Objective: To investigate the incidence of lateral neck node occult metastasis and to show the usefulness of sentinel lymph node biopsy (SLNB) in the detection of lateral neck node metastasis in thyroid carcinoma, the investigators used a radioisotope to detect the sentinel lymph node. Summary Background Data: Although occult lymph node metastasis to the lateral neck compartment is common in papillary thyroid carcinoma, the incidence and patterns of lateral neck node metastasis in papillary carcinoma are not known.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Jun 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 2, 2010
CompletedFirst Posted
Study publicly available on registry
June 4, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedApril 21, 2016
April 1, 2016
1.6 years
June 2, 2010
April 20, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
The usefulness of lateral sentinel lymph node biopsy in PTC
at Oct 2011
Study Arms (2)
Lateral sentinel group
ACTIVE COMPARATORLateral sentinel lymph node biopsy with radioisotope
No intervention for lateral neck
NO INTERVENTIONNo lateral sentinel lymph node biopsy with radioisotope
Interventions
Sentinel lymph node biopsy with radioisotope. Isotope injection and lymphoscintigraphy preoperatively
Eligibility Criteria
You may qualify if:
- Cases with tumors larger than 1 cm in size or with suspicious central neck node metastasis in Papillary thyroid cancer
You may not qualify if:
- The patient with definite metastatic lymph node in lateral neck compartment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsung Medical Center
Seoul, 135-710, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Se Kyung Lee, M.D
Samsung Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Association professor
Study Record Dates
First Submitted
June 2, 2010
First Posted
June 4, 2010
Study Start
June 1, 2009
Primary Completion
January 1, 2011
Study Completion
January 1, 2011
Last Updated
April 21, 2016
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will not share